These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
627 related articles for article (PubMed ID: 24963568)
1. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. Boulware DR; Meya DB; Muzoora C; Rolfes MA; Huppler Hullsiek K; Musubire A; Taseera K; Nabeta HW; Schutz C; Williams DA; Rajasingham R; Rhein J; Thienemann F; Lo MW; Nielsen K; Bergemann TL; Kambugu A; Manabe YC; Janoff EN; Bohjanen PR; Meintjes G; N Engl J Med; 2014 Jun; 370(26):2487-98. PubMed ID: 24963568 [TBL] [Abstract][Full Text] [Related]
2. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426 [TBL] [Abstract][Full Text] [Related]
3. Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa. Molloy SF; Kanyama C; Heyderman RS; Loyse A; Kouanfack C; Chanda D; Mfinanga S; Temfack E; Lakhi S; Lesikari S; Chan AK; Stone N; Kalata N; Karunaharan N; Gaskell K; Peirse M; Ellis J; Chawinga C; Lontsi S; Ndong JG; Bright P; Lupiya D; Chen T; Bradley J; Adams J; van der Horst C; van Oosterhout JJ; Sini V; Mapoure YN; Mwaba P; Bicanic T; Lalloo DG; Wang D; Hosseinipour MC; Lortholary O; Jaffar S; Harrison TS; N Engl J Med; 2018 Mar; 378(11):1004-1017. PubMed ID: 29539274 [TBL] [Abstract][Full Text] [Related]
4. Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis. Eshun-Wilson I; Okwen MP; Richardson M; Bicanic T Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009012. PubMed ID: 30039850 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study. Rhein J; Morawski BM; Hullsiek KH; Nabeta HW; Kiggundu R; Tugume L; Musubire A; Akampurira A; Smith KD; Alhadab A; Williams DA; Abassi M; Bahr NC; Velamakanni SS; Fisher J; Nielsen K; Meya DB; Boulware DR; Lancet Infect Dis; 2016 Jul; 16(7):809-818. PubMed ID: 26971081 [TBL] [Abstract][Full Text] [Related]
12. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. Saag MS; Powderly WG; Cloud GA; Robinson P; Grieco MH; Sharkey PK; Thompson SE; Sugar AM; Tuazon CU; Fisher JF N Engl J Med; 1992 Jan; 326(2):83-9. PubMed ID: 1727236 [TBL] [Abstract][Full Text] [Related]
13. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi. Nussbaum JC; Jackson A; Namarika D; Phulusa J; Kenala J; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; Kamwendo D; van der Horst CM; Harrison TS Clin Infect Dis; 2010 Feb; 50(3):338-44. PubMed ID: 20038244 [TBL] [Abstract][Full Text] [Related]
14. Determinants of two-year mortality among HIV positive patients with Cryptococcal meningitis initiating standard antifungal treatment with or without adjunctive dexamethasone in Uganda. Kitonsa J; Nsubuga R; Mayanja Y; Kiwanuka J; Nikweri Y; Onyango M; Anywaine Z; Ggayi AB; Kibengo FM; Kaleebu P; Day J PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008823. PubMed ID: 33253210 [TBL] [Abstract][Full Text] [Related]
15. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Bicanic T; Meintjes G; Wood R; Hayes M; Rebe K; Bekker LG; Harrison T Clin Infect Dis; 2007 Jul; 45(1):76-80. PubMed ID: 17554704 [TBL] [Abstract][Full Text] [Related]
16. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. Bicanic T; Wood R; Meintjes G; Rebe K; Brouwer A; Loyse A; Bekker LG; Jaffar S; Harrison T Clin Infect Dis; 2008 Jul; 47(1):123-30. PubMed ID: 18505387 [TBL] [Abstract][Full Text] [Related]
17. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes. Jarvis JN; Bicanic T; Loyse A; Namarika D; Jackson A; Nussbaum JC; Longley N; Muzoora C; Phulusa J; Taseera K; Kanyembe C; Wilson D; Hosseinipour MC; Brouwer AE; Limmathurotsakul D; White N; van der Horst C; Wood R; Meintjes G; Bradley J; Jaffar S; Harrison T Clin Infect Dis; 2014 Mar; 58(5):736-45. PubMed ID: 24319084 [TBL] [Abstract][Full Text] [Related]
18. Optimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis. Njei B; Kongnyuy EJ; Kumar S; Okwen MP; Sankar MJ; Mbuagbaw L Cochrane Database Syst Rev; 2013 Feb; (2):CD009012. PubMed ID: 23450595 [TBL] [Abstract][Full Text] [Related]
19. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients. Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072 [TBL] [Abstract][Full Text] [Related]
20. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. Blanc FX; Sok T; Laureillard D; Borand L; Rekacewicz C; Nerrienet E; Madec Y; Marcy O; Chan S; Prak N; Kim C; Lak KK; Hak C; Dim B; Sin CI; Sun S; Guillard B; Sar B; Vong S; Fernandez M; Fox L; Delfraissy JF; Goldfeld AE; N Engl J Med; 2011 Oct; 365(16):1471-81. PubMed ID: 22010913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]